Final answer:
When a patient with Deep Vein Thrombosis is noncompliant with warfarin therapy, alternative anticoagulation medications like DOACs or low molecular weight heparin may be used, coupled with lifestyle changes to reduce the risk of serious complications such as pulmonary embolism.
Step-by-step explanation:
The primary treatment for Deep Vein Thrombosis (DVT) in a patient who is noncompliant with warfarin therapy typically involves alternative anticoagulation medications. Warfarin is a commonly prescribed anticoagulant for DVT, but in cases where a patient is noncompliant or unable to take this medication, other drugs like direct oral anticoagulants (DOACs) such as rivaroxaban, apixaban, and dabigatran may be used.
These DOACs do not require the regular monitoring that warfarin does and have fewer dietary restrictions, which can improve patient compliance. It is essential for patients with DVT to be managed with some form of anticoagulation therapy to prevent the serious risk of the clot dislodging and causing a pulmonary embolism, which can be life-threatening. Additionally, lifestyle modifications, such as regular leg exercises, wearing compression stockings, and avoiding prolonged periods of inactivity, can help reduce the risk of DVT complications. If the patient continues to be noncompliant with oral anticoagulation therapy, the healthcare provider may explore the use of injectable anticoagulants, such as low molecular weight heparin.